Human immunodeficiency virus-associated anaplastic large cell lymphoma

Leukemia and Lymphoma

Volumn 51, Issue 3, 2010, Pages 430-438

  Perez, Kimberly ^a   Castillo, Jorge ^a   Dezube, Bruce J ^b   Pantanowitz, Liron ^c  

^a BROWN UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALCL; ALK; Anaplastic large cell lymphoma; HIV

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE; CD30 ANTIGEN;

AGE DISTRIBUTION; ANALYSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS INFECTION; ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CHILD; COMPLICATION; FEMALE; INFANT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD30; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MIDDLE AGED; PROGNOSIS;

EID: 77249166553     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903572201     Document Type: Article

References (66)

1. Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008;26:4834-4842.
2. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34:121-130.
3. Shibata D, Weiss LM, Hernandez AM, et al. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993;81: 2102-2109.
4. Carbone A, Cesarman E, Spina M, et al. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009; 13:1213-1224.
5. Castillo J, Perez K, Milani C, et al. Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review. J HIV Ther 2009;14:34-40.
6. Biggar RJ, Engels EA, Frisch M, et al. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 2001;26:371-376.
7. Fornari A, Piva R, Chiarle R, et al. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma Hematol Oncol 2009;27:161-170.
8. Beltran B, Morales D, Quinones P, et al. Distribution and pathology characteristics of non Hodgkin lymphoma in Peru: a study of 1014 cases using WHO Classification of Lymphoid Neoplasm. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110:4419.
9. Aozasa K, Takakuwa T, Hongyo T, et al. Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 2008;87:110-117.
10. Swerdlow S, Campo E, Harris N, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
11. Castillo J, Pantanowitz L. HIV-Associated NK/T-cell lymphomas: a review of 93 cases. Blood 2007;110(Suppl. 1): 1013a (Abstract 3457).
12. Amin HM, Lai R. Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 2007;110:2259-2267.
13. Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008; 111:5496-5504.
14. Arber DA, Chang KL, Weiss LM. Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases. Am J Surg Pathol 1999;23:519-522.
15. Arzoo KK, Bu X, Espina BM, et al. T-cell lymphoma in HIVinfected patients. J Acquir Immune Defic Syndr 2004;36: 1020-1027.
16. Baschinsky DY, Weidner N, Baker PB, et al. Primary hepatic anaplastic large-cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome: a report of an autopsy case and review of the literature. Am J Gastroenterol 2001; 96:227-232.
17. Beylot-Barry M, Vergier B, Masquelier B, et al. The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol 1999;23:1208-1216. (Pubitemid 29474590)
18. Bozner P, Elkhalifa MY. Anaplastic large cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome. South Med J 1997;90:559-566.
19. Burke AP, Andriko JA, Virmani R. Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIVpositive man. Cardiovasc Pathol 2000;9:49-52.
20. Cai G, Inghirami G, Moreira A, et al. Primary hepatic anaplastic large-cell lymphoma diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol 2005;33:106-109.
21. Chadburn A, Cesarman E, Jagirdar J, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993;72: 3078-3090.
22. Chow DC, SH Be, Eickhoff L, et al. Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer. Am J Gastroenterol 1996;91:602-603.
23. Diekman MJ, Bresser P, Noorduyn LA, et al. Spontaneous regression of Ki-1 positive T-cell non-Hodgkin's lymphoma in a patient with HIV infection. Br J Haematol 1992;82: 477-478.
24. Dunphy CH, Collins B, Ramos R, et al. Secondary pleural involvement by an AIDS-related anaplastic large cell (CD30+) lymphoma simulating metastatic adenocarcinoma. Diagn Cytopathol 1998;18:113-117.
25. Escobedo Palau JA, Rubio Felix SA, Gracia Nasarre M, et al. [Large T-cell (Ki-1) anaplastic lymphoma in a patient with human immunodeficiency virus infection, an exceptional association]. Rev Clin Esp 1995;195:126-127.
26. Fatkenheuer G, Hell K, Roers A, et al. Spontaneous regression of HIV associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy. Eur J Med Res 2000; 5:236-240.
27. Gonzalez-Clemente JM, Ribera JM, Campo E, et al. Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIVinfected patient. AIDS 1991;5:751-755.
28. Hicks MJ, Flaitz CM, Nichols CM, et al. Intraoral presentation of anaplastic large-cell Ki-1 lymphoma in association with HIV infection. Oral Surg Oral Med Oral Pathol 1993;76:73-81.
29. Jhala DN, Medeiros LJ, Lopez-Terrada D, et al. Neutrophilrich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients. Am J Clin Pathol 2000;114:478-482.
30. Kottilil S, Fram R, Cortez K, et al. Hypercalcemia and T-cell lymphoma with acquired immunodeficiency syndrome: occurrence without human T-cell leukemia virus-I. South Med J 2000;93:894-897.
31. Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1- positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 1995;19:407-416.
32. Mira JA, Fernandez-Alonso J, Macias J, et al. Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient. J Infect 2003;47:73-76.
33. Nagajothi N, Dham SK, Gelfand Y, et al. Treatment of AIDSassociated anaplastic large-cell lymphoma with dose-adjusted EPOCH chemotherapy. J Natl Med Assoc 2007;99:799-801.
34. Nava VE, Cohen P, Kalan M, et al. HIV-associated anaplastic large cell lymphoma: a report of three cases. AIDS 2008;22: 1892-1894.
35. Nosari A, Cantoni S, Oreste P, et al. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients. Br J Haematol 1996;95:508-512.
36. Pantanowitz L, Castillo J, Freeman JK, et al. Images in HIV/ AIDS. Fatal HIV-associated anaplastic large-cell lymphoma. AIDS Read 2009;19:19-21.
37. Piira TA, Ries K, Kjeldsberg CR, et al. Anaplastic large-cell lymphoma presenting primarily in bone in a patient with AIDS. Hematol Pathol 1994;8:111-116.
38. Proca DM, De Renne L, Marsh WL Jr, et al. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: a case report. Acta Cytol 2008;52:83-86.
39. Rowsell EH, Zekry N, Liwnicz BH, et al. Primary anaplastic lymphoma kinase-negative anaplastic large cell lymphoma of the brain in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 2004;128:324-327.
40. Rush WL, Andriko JA, Taubenberger JK, et al. Primary anaplastic large cell lymphoma of the lung: a clinicopathologic study of five patients. Mod Pathol 2000;13:1285-1292.
41. Samuels MH, Launder T. Hyperthyroidism due to lymphoma involving the thyroid gland in a patient with acquired immunodeficiency syndrome: case report and review of the literature. Thyroid 1998;8:673-677.
42. Willard CC, Foss RD, Hobbs TJ, et al. Primary anaplastic large cell (KI-1 positive) lymphoma of the mandible as the initial manifestation of acquired immunodeficiency syndrome in a pediatric patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:67-70.
43. Mason D, Harris N, Delsol G, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer; 2008. pp. 317- 319.
44. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008;83:804-809.
45. Lim ST, Karim R, Nathwani BN, et al. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the prehighly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 2005;23:4430-4438.
46. Bedimo RJ, McGinnis KA, Dunlap M, et al. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 2009 Jul 16. [Epub ahead of print].
47. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000;18:3707-3721.
48. Iannitto E, Ferreri AJ, Minardi V, et al. Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol 2008;68:264-271.
49. Lee Y, Lee KW, Kim JH, et al. Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma. Korean J Intern Med 2008;23:30-36.
50. Dupuis J, Emile JF, Mounier N, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006;108:4163-4169.
51. Hoffmann C, Wolf E, Fatkenheuer G, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 2003;17: 1521-1529.
52. Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 2002;98:916-922.
53. Wolf T, Brodt HR, Fichtlscherer S, et al. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2005; 46:207-215.
54. Franceschi S, Maso LD, Rickenbach M, et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 2008;99:800-804.
55. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009;100:840-847.
56. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194.
57. Park SJ, Kim S, Lee DH, et al. Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center. Yonsei Med J 2008;49:601-609.
58. Suzuki R, Kagami Y, Takeuchi K, et al. Prognostic significance of CD56 expression for ALK-positive and ALKnegative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 2000;96:2993-3000.
59. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALKnegative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects-a review. J Pathol 2003; 200:4-15.
60. Wang FH, Li YH, Zeng J, et al. Clinical analysis of primary systemic anaplastic large cell lymphoma: a report of 57 cases. Chin J Cancer 2009;28:49-53.
61. Lim ST, Karim R, Tulpule A, et al. Prognostic factors in HIVrelated diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 2005;23: 8477-8482.
62. Miralles P, Berenguer J, Ribera JM, et al. Prognosis of AIDSrelated systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 2007;44:167-173.
63. Navarro JT, Ribera JM, Oriol A, et al. International prognostic index is the best prognostic factor for survival in patientswithAIDSrelated non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients. Haematologica 1998;83: 508-513.
64. Rossi G, Donisi A, Casari S, et al. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virusrelated systemic non-Hodgkin lymphoma. Cancer 1999;86: 2391-2397.
65. Tanaka PY, Pracchia LF, Bellesso M, et al. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil. Ann Hematol 2009 Jun 4. [Epub ahead of print].
66. Bower M, Gazzard B, Mandalia S, et al. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med 2005;143:265-273.